146 related articles for article (PubMed ID: 31606312)
1. The long-term effectiveness of metabolic control on cardiovascular disease in patients with diabetes in a real-world health care setting - A prospective diabetes management study.
Chen S; Hou X; Zhou X; Yu J; Xue H; Hu G; Sun Y; Chen P; Wu J; Liang Y; Bao Y; Jia W
Prim Care Diabetes; 2020 Jun; 14(3):274-281. PubMed ID: 31606312
[TBL] [Abstract][Full Text] [Related]
2. Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
de Ritter R; Sep SJS; van der Kallen CJH; Schram MT; Koster A; Kroon AA; van Greevenbroek MMJ; Eussen SJPM; Dagnelie PC; de Jong M; Vos RC; Woodward M; Bots ML; Peters SAE; Stehouwer CDA
BMJ Open Diabetes Res Care; 2019; 7(1):e000787. PubMed ID: 31798903
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.
Du T; Yuan G; Zhou X; Sun X
Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477
[TBL] [Abstract][Full Text] [Related]
4. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
[TBL] [Abstract][Full Text] [Related]
5. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
6. Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.
Ren Y; Ren Q; Lu J; Guo X; Huo X; Ji L; Yang X
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29124871
[TBL] [Abstract][Full Text] [Related]
7. Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?
Lind L; Ingelsson E; Ärnlöv J; Sundström J; Zethelius B; Reaven GM
Metab Syndr Relat Disord; 2018 Oct; 16(8):433-439. PubMed ID: 30183521
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.
Zhou H; Zhang C; Ni J; Han X
BMC Endocr Disord; 2019 Oct; 19(1):98. PubMed ID: 31601203
[TBL] [Abstract][Full Text] [Related]
9. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
10. Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
Wright AK; Suarez-Ortegon MF; Read SH; Kontopantelis E; Buchan I; Emsley R; Sattar N; Ashcroft DM; Wild SH; Rutter MK
Circulation; 2020 Nov; 142(20):1925-1936. PubMed ID: 33196309
[TBL] [Abstract][Full Text] [Related]
11. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
12. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
Nichols GA; Joshua-Gotlib S; Parasuraman S
J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
[TBL] [Abstract][Full Text] [Related]
13. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
Jiang R; Schulze MB; Li T; Rifai N; Stampfer MJ; Rimm EB; Hu FB
Diabetes Care; 2004 Aug; 27(8):1991-7. PubMed ID: 15277429
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
Shi X; He J; Lin M; Liu C; Yan B; Song H; Wang C; Xiao F; Huang P; Wang L; Li Z; Huang Y; Zhang M; Chen CS; Obst K; Li W; Yang S; Yao G; Li X
Am Heart J; 2021 Aug; 238():45-58. PubMed ID: 33957103
[TBL] [Abstract][Full Text] [Related]
15. Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022.
Zou YW; Wu T; Li QH; Ma JD; Pan J; Lu Y; Lin JZ; Jia PW; Zheng HW; Gao JW; Dai W; Mo YQ; Dai J; Dai L
Int J Cardiol; 2024 Jun; 405():131947. PubMed ID: 38458390
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors for cardiovascular disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
Wan EY; Fong DY; Fung CS; Lam CL
J Diabetes Complications; 2016 Apr; 30(3):444-50. PubMed ID: 26774791
[TBL] [Abstract][Full Text] [Related]
19. Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.
Cook CB; Hentz JG; Tsui C; Ziemer DC; Naylor DB; Miller WJ
Ethn Dis; 2006; 16(4):852-8. PubMed ID: 17061737
[TBL] [Abstract][Full Text] [Related]
20. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies.
Ye X; Kong W; Zafar MI; Chen LL
Cardiovasc Diabetol; 2019 Apr; 18(1):48. PubMed ID: 30987625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
